Sol-Gel Technologies Ltd.
TREATMENT OF OCULAR DISEASES WITH OPHTHALMIC TAPINAROF COMPOSITIONS
Last updated:
Abstract:
The present invention relates to the treatment of an ocular inflammatory disease or an ocular degeneration disease by ophthalmic administration of a composition comprising tapinarof and optionally at least one additional active agent. Specifically, the ocular inflammatory disease is blepharitis. This invention provides a treatment of blepharitis and Demodex mites.
Status:
Application
Type:
Utility
Filling date:
16 Nov 2021
Issue date:
10 Mar 2022